Analysis of EGFR mutation using highly sensitive droplet digital PCR in non-small cell lung cancer patients with EGFR mutations.

Not Applicable

• Conditions: lung cancer

• Registration Number: JPRN-UMIN000038648
• Lead Sponsor: agasaki University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-22
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients cannot ingest EGFR-TKIs. 2)Patients with paresis of intestine or ileus of intestine. 3)With chronic diarrhea. 4)Interstitial pulmonary disease, drug-induced interstitial pulmonary disease and irradiation pneumonitis clearly detected by chest CT. 5)Uncontrollable pleural/ abdominal/ pericardial effusion. 6)Symptomatic brain metastasis required for radiation therapy or surgical resection. 7)Patients with a radiation therapy included lung field within 28 days before enrollment. 8)Active infection to need systemic treatment. 9)Patients with severe complications (bleeding of digestive tract, heart disease, glaucoma, diabetes, etc.). 10)Patients who are different for the participation in the study by complication of mental disease or psychiatric symptom. 11)Patients with pregnant or possibly pregnant, nursing. 12)Any other patients regarded as unsuitable for this study by the investigators.

Study & Design

• Study Type: Observational
• Study Design: Not specified